Using epigenetic analysis to understand the biology of relapse in AML
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2023-03-23
Просмотров: 206
Описание:
Ravi Majeti, MD, PhD, Stanford University, Stanford, CA, comments on the use of chromatin biology methods to understand the processes driving relapse in patients with acute myeloid leukemia (AML). Dr Majeti explains that in patients without mutational changes between diagnosis and relapse, methods like ATAC-seq have identified the presence of epigenetic features leading to relapse. This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
